CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Also, we found that the miR-155 knocking down has led to the up-regulation of SMAD5 and TGF-βR2 gene expression in CD34+ CML cells (Figure 2H, I(Fig. 2)).